pharmaceutical

Patients Taking AUSTEDO XR (deutetrabenazine) extended-release tablets Reported Symptom Improvement and High Satisfaction

Of the 209 patients with tardive dyskinesia (TD) that were surveyed, >94% reported movement improvement once treated with AUSTEDO XR®…

4 days ago

Bright Green Corporation Merges with PharmAGRI Capital Partners; Lynn Stockwell Appointed CEO and Chairwoman

Tesla Robotics to Power Sovereign “Seed to Syringe” Pharmaceutical Infrastructure Fort Lauderdale, FL, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Bright…

1 week ago

Servier acquires potential treatment for Fragile X syndrome, the most common genetic cause of autism spectrum disorder

Servier acquires KER-0193, a potential treatment for Fragile X syndrome, developed by Kaerus Bioscience, a Medicxi companyKER-0193, a novel, orally bioavailable…

2 weeks ago

Gateway to Growth: Innovation and Opportunity at the 8th CIIE

SHANGHAI, Aug. 29, 2025 /PRNewswire/ -- Amid a shifting global economy, the China International Import Expo (CIIE) continues to provide a…

4 weeks ago

Caliber Enters 25th Year of Empowering Global Pharma with GxP Digital Solutions

HYDERABAD, India, Aug. 11, 2025 /PRNewswire/ -- Caliber, a leading global provider of GxP-compliant digital solutions for the life sciences…

2 months ago

XORTX Completes USD $114,500 Private Placement

August 08, 2025 19:54 ET  | Source: XORTX Therapeutics Inc. NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICESOR FOR…

2 months ago

Fermenta Announces Granting of CEP by EDQM for VITADEE 100 SD, Enabling Accelerated Global Growth

THANE, India, July 30, 2025 /PRNewswire/ -- Fermenta Biotech Limited ("Fermenta"), a pioneer in pharmaceutical and nutritional ingredients; one of the…

2 months ago

Colorcon Celebrates Grand Opening of New Manufacturing Facility in Malaysia

Johor plant is Colorcon's 7th major film coating plant and 16th manufacturing facility worldwide HARLEYSVILLE, Pa. and JOHOR, Malaysia, July…

2 months ago

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

July 18, 2025 16:30 ET  | Source: Ultragenyx Pharmaceutical Inc. NOVATO, Calif., July 18, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical…

2 months ago

Ultragenyx Receives Complete Response Letter from FDA for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)

July 11, 2025 16:30 ET  | Source: Ultragenyx Pharmaceutical Inc. Complete Response Letter (CRL) cited specific chemistry, manufacturing and controls…

3 months ago